GMKBPublic Meeting: FDA Rare Disease Day
Monday, February 27 | 9 a.m.-4:45 p.m. ET | Online The U.S. Food and Drug Administration (FDA) will host Rare Disease Day, a virtual public meeting, on February 27, in […]
- GUARDD-US APOL1 Genetic Testing Manuscript Published March 6, 2026
A new manuscript from the IGNITE Pragmatic Trials Network has been published in JAMA Network Open, describing the primary results of the GUARDD-US study. GUARDD-US is a randomized controlled trial examining the impact of returning APOL1 genetic risk results to ...
- GUARDD-US APOL1 Genetic Testing Manuscript Published March 6, 2026